347 related articles for article (PubMed ID: 12093886)
1. Increased ABCA1 activity protects against atherosclerosis.
Singaraja RR; Fievet C; Castro G; James ER; Hennuyer N; Clee SM; Bissada N; Choy JC; Fruchart JC; McManus BM; Staels B; Hayden MR
J Clin Invest; 2002 Jul; 110(1):35-42. PubMed ID: 12093886
[TBL] [Abstract][Full Text] [Related]
2. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
[TBL] [Abstract][Full Text] [Related]
3. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
Thorngate FE; Yancey PG; Kellner-Weibel G; Rudel LL; Rothblat GH; Williams DL
J Lipid Res; 2003 Dec; 44(12):2331-8. PubMed ID: 12951361
[TBL] [Abstract][Full Text] [Related]
4. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.
Aiello RJ; Brees D; Bourassa PA; Royer L; Lindsey S; Coskran T; Haghpassand M; Francone OL
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):630-7. PubMed ID: 11950702
[TBL] [Abstract][Full Text] [Related]
5. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
7. Distinct cellular loci for the ABCA1-dependent and ABCA1-independent lipid efflux mediated by endogenous apolipoprotein E expression.
Huang ZH; Fitzgerald ML; Mazzone T
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):157-62. PubMed ID: 16254198
[TBL] [Abstract][Full Text] [Related]
8. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.
Vaisman BL; Lambert G; Amar M; Joyce C; Ito T; Shamburek RD; Cain WJ; Fruchart-Najib J; Neufeld ED; Remaley AT; Brewer HB; Santamarina-Fojo S
J Clin Invest; 2001 Jul; 108(2):303-9. PubMed ID: 11457883
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice.
Burgess B; Naus K; Chan J; Hirsch-Reinshagen V; Tansley G; Matzke L; Chan B; Wilkinson A; Fan J; Donkin J; Balik D; Tanaka T; Ou G; Dyer R; Innis S; McManus B; Lütjohann D; Wellington C
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1731-7. PubMed ID: 18599800
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
[TBL] [Abstract][Full Text] [Related]
11. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.
Su YR; Dove DE; Major AS; Hasty AH; Boone B; Linton MF; Fazio S
Circulation; 2005 May; 111(18):2373-81. PubMed ID: 15851589
[TBL] [Abstract][Full Text] [Related]
12. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
Wang N; Lan D; Chen W; Matsuura F; Tall AR
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
[TBL] [Abstract][Full Text] [Related]
13. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
[TBL] [Abstract][Full Text] [Related]
14. Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters.
Su YR; Ishiguro H; Major AS; Dove DE; Zhang W; Hasty AH; Babaev VR; Linton MF; Fazio S
Mol Ther; 2003 Oct; 8(4):576-83. PubMed ID: 14529830
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo.
Chung S; Sawyer JK; Gebre AK; Maeda N; Parks JS
Circulation; 2011 Oct; 124(15):1663-72. PubMed ID: 21931081
[TBL] [Abstract][Full Text] [Related]
16. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
17. Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1.
Francone OL; Subbaiah PV; van Tol A; Royer L; Haghpassand M
Biochemistry; 2003 Jul; 42(28):8569-78. PubMed ID: 12859204
[TBL] [Abstract][Full Text] [Related]
18. Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice.
Van Eck M; Singaraja RR; Ye D; Hildebrand RB; James ER; Hayden MR; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):929-34. PubMed ID: 16456089
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway.
Pamir N; Hutchins P; Ronsein G; Vaisar T; Reardon CA; Getz GS; Lusis AJ; Heinecke JW
J Lipid Res; 2016 Feb; 57(2):246-57. PubMed ID: 26673204
[TBL] [Abstract][Full Text] [Related]
20. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
Amar MJ; D'Souza W; Turner S; Demosky S; Sviridov D; Stonik J; Luchoomun J; Voogt J; Hellerstein M; Sviridov D; Remaley AT
J Pharmacol Exp Ther; 2010 Aug; 334(2):634-41. PubMed ID: 20484557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
